Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/10 → 4/30/13 |
Funding
- Janssen Alzheimer Immunotherapy Research and Development LLC: $141,374.00
301 - Trial of Bapineuzumab in Patients with Mild to Moderate AD who are Apolipoprotein E4 Epsilon4 NON-Carriers
- Jicha, Gregory (PI)
- Caban-Holt, Allison (CoI)
- Freeman, Stephanie (CoI)
- Hamon, Robin (CoI)
- Howe, Jeffrey (CoI)
- Smart, Marie (CoI)
- Smith, Charles (CoI)
- Cooper, Gregory (Former CoI)
- Newsham, Patrick (Former CoI)